Abstract
Abstract: Mutations affecting T-cell receptor (TCR) signaling typically cause combined immunodeficiency (CID) due to varying degrees of disturbed T-cell homeostasis and differentiation. Here, we describe two cousins with CID due to a novel nonsense mutation in LCK and investigate the effect of this novel nonsense mutation on TCR signaling, T-cell function, and differentiation. Patients underwent clinical, genetic, and immunological investigations. The effect was addressed in primary cells and LCK-deficient T-cell lines after expression of mutated LCK. Results: Both patients primarily presented with infections in early infancy. The LCK mutation led to reduced expression of a truncated LCK protein lacking a substantial part of the kinase domain and two critical regulatory tyrosine residues. T cells were oligoclonal, and especially naïve CD4 and CD8 T-cell counts were reduced, but regulatory and memory including circulating follicular helper T cells were less severely affected. A diagnostic hallmark of this immunodeficiency is the reduced surface expression of CD4. Despite severely impaired TCR signaling mTOR activation was partially preserved in patients’ T cells. LCK-deficient T-cell lines reconstituted with mutant LCK corroborated partially preserved signaling. Despite detectable differentiation of memory and effector T cells, their function was severely disturbed. NK cell cytotoxicity was unaffected. Residual TCR signaling in LCK deficiency allows for reduced, but detectable T-cell differentiation, while T-cell function is severely disturbed. Our findings expand the previous report on one single patient on the central role of LCK in human T-cell development and function. Graphical Abstract: [Figure not available: see fulltext.]
Original language | English |
---|---|
Article number | 4 |
Journal | Journal of Clinical Immunology |
Volume | 44 |
Issue number | 1 |
DOIs | |
State | Published - 19 Dec 2023 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2023, The Author(s).
Funding
Open Access funding enabled and organized by Projekt DEAL. P.S. and K.W. were supported by the DFG (Discovery and Evaluation of New Combined Immunodeficiency Disease Entities; grant DFG WA 1597/4–1). S.M. is supported by the German Research Foundation (DFG) through BIOSS—EXC294 and CIBSS—EXC 2189; SFB1160 (Project ID: 256073931—B01 to SM) and MI1942/5–1 (Project ID: 501436442). B.S. is supported by the DFG through CRC854 (Project B19) as well as by two grants of the state of Saxony-Anhalt (SI-2 and SI3, respectively). R.S. and Y.N.L are supported by the ISF (Israeli Science Foundation, under the Israel Precision Medicine Program (IPMP), grant agreement No. 3115/19). The authors would like to thank the patients and their families, the treating physicians and nurses. We thank A. Weiss for sharing LCK-deficient Jurkat T cells (Jk.LCKKO) and Roland Hartig for technical support. Part of Fig. and the graphical abstract were created with biorender.org. We would like to acknowledge the Lighthouse Core Facility for their assistance with FACS analysis.
Funders | Funder number |
---|---|
Deutsche Forschungsgemeinschaft | CIBSS—EXC 2189, CRC854, EXC294, MI1942/5–1, SFB1160, 256073931—B01, 501436442 |
Israel Science Foundation | 3115/19 |
Keywords
- LCK
- T cells
- TCR signaling
- combined immunodeficiency
- diagnosis
- low CD4 expression